期刊文献+

针对uPA的siRNA对人乳腺癌细胞侵袭的抑制作用 被引量:1

Inhibition of Invasiveness of Human Breast Cancer Cells by siRNA Against Urokinase-type Plasminogen Activator
下载PDF
导出
摘要 目的:通过RNA干涉的方法抑制乳腺癌细胞中uPA的表达,观察uPA的表达抑制后对肿瘤细胞的体外侵袭能力的影响。方法:(1)构建可以表达针对uPA的siRNA的干涉载体,转染高侵袭性人乳腺癌细胞系MDA-MB 231,G418抗性筛选,挑选单克隆株;(2)分别通过RT-PCR和Western Blot的方法检测uPA的表达;(3)平板克隆形成试验检测转染前后肿瘤细胞的克隆形成能力;4Bovden chamber Assay检测肿瘤细胞体外侵袭能力。结果:(1)可以稳定表达针对uPA的siRNA的单克隆株,uPA的表达水平显著下降;(2)转染了针对uPA的siRNA的单克隆株的克隆形成能力降低;(3)转染了针对uPA的siRNA的单克隆株体外侵袭能力与原代细胞MDA-MB 231相比明显受到抑制。结论:uPA在人乳腺癌侵袭行为中发挥重要的作用,针对uPA的siRNA可以显著降低uPA的表达,从而抑制肿瘤细胞的侵袭,可望成为抗肿瘤侵袭治疗的一种有效手段。 Objective:To inhibit the metastasis of breast cancer cell line MDA-MB 231 by means of silencing the expression of uPA. Methods: The vectors expressing siRNA against uPA were contructed and introduced into highly invasive breast cancer cell line MDA-MB 231 with lipofectin and positive single colonies were screened out with G418. RT-PCR and Western Blot were performed to detect the expression of uPA.Colony forming test was applied to detect the ability of cancer cell to form colony.The in vitro invasive ability of cancer cells was defined with Boyden Chamber Assay.Results:One of the colonies Al was found to express siRNA against uPA effectively because the expression of uPA in this colony was significantly decreased. The result from colony forming test indicated that the ability of Al to form colony is inhibited compared with that of untransfected MDA-MB 231 cell. The in vitro invasive ability of the clone A1 was significantly decreased. Conclusion: The siRNA against uPA can inhibit the expression of uPA and siginificantly decrease the invasive ability of at least a kind of cancer cell lines.RNAi is expected to become an effective method in anti-invasion therapy of cancers.
出处 《中国生物工程杂志》 CAS CSCD 北大核心 2005年第6期31-35,共5页 China Biotechnology
基金 "973"计划资助项目(2004CB518805) "863"计划资助项目(2004AA217071)
关键词 人乳腺癌细胞 RNA干涉 UPA 抑制作用 体外侵袭能力 尿激酶 肿瘤侵袭 Urokinase-type plasminogen activitor Urokinase RNAi Metastasis Boyden Chamber Assay
  • 相关文献

参考文献12

  • 1Duffy M J, Duggan C. The urokinase plasminogen activator system: a rich source of tumour markers for the individualised management of patients with cancer. Clin Biochem, 2004, 37(7) :541 ~ 548
  • 2Hiendlmeyer E, Regus S, Wassermann S, et al. Beta-catenin upregulates the expression of the urokinase plasminogen activator in human colorectal tumors. Cancer Res, 2004, 64(4):1209 ~ 1214
  • 3Aflalo E D, Sod-Moriah U A, Potashnik G, et al. Expression of plasminogen activators in preimplantation rat embryos developed in vivo and in vitro. Reprod Biol Endocrinol, 2005,3(1): 7
  • 4Milhavet O, Gary D S, Mattson M P. RNA interference in biology and medicine. Pharmacol Rev, 2003, 55(4) :629 ~ 648
  • 5吴青.RNAi技术研究进展[J].中国生物工程杂志,2003,23(1):92-96. 被引量:5
  • 6Scherr M, Battmer K, Schultheis B, et al. Stable RNA interference (RNAi) as an option for anti-bcr-abl therapy. Gene Ther, 2005, 12(1):12~21
  • 7Duursma A M, Agami R. Ras interference as cancer therapy.Semin Cancer Biol, 2003, 13(4) :267 ~ 273
  • 8Wohlbold L, van der Kuip H, Miething C, et al. Inhibition of bcrabl gene expression by small interfering RNA sensitizes for imatinib mesylate (STI571). Blood, 2003, 102(6):2236~2239
  • 9Brummelkamp T R, Bernards R, Agami R, et al. A system for stable expression of short interfering RNAs in mammalian cells.Sicence, 2002, 296:550 ~ 553
  • 10Muller B A,Homey H, Soto H, et al. Involvement of chemokine receptors in breast cancer metastasis. Nature, 2001, 410:50~ 56

共引文献4

同被引文献8

  • 1程联胜,查昭,席甲甲,江冰,刘兢,姚雪彪.慢病毒介导的RNA干涉对乳腺癌SKBR3细胞HER2受体的下调及生长抑制[J].中国生物工程杂志,2007,27(2):1-8. 被引量:7
  • 2Graft J R, Zimmer S G. Translational control and metastatic progression:enhanced activity of the mRNA cap-binding protein elF-4E selectively enhances translation of metastasis related mRNAs. Clin Exp Metastasis ,2003,20 (3) :265 - 273.
  • 3Li Y S , Kaneko M , Amatya V I, et al. Expression of vascular endothelial growth factor- C and its receptor in invasive micropapillary carcinoma of the breast. Pathol Int, 2006, 56 (5) :256 -261.
  • 4De Benedetti A, Graft J R. elF-4E expression and its role in malignancies and metastases. Oncogene,2004,23 ( 18 ) : 3189 - 3199.
  • 5ByrnesK, White S, Chu Q, et al. High elF -4E, VEGF and microvessel density in stage Ⅰ to Ⅲ breast cancer. Ann Surg, 2006,243(5) :684 - 690.
  • 6Fremowitz F B,Viola M V,Chao S,et al. Ras p21 expression in the progression of breast cancer. Human Pathol, 1987,18 : 1268 1275.
  • 7Weidner N, Folkman J, Pozza F, et al. Tumor angiogenesis: a new significant and independent prognostic indicator in earlystage breast carcinoma. J Natl Cancer Inst, 1992,84 (24) ;1875 - 1887.
  • 8Mc Clusky D R, Chu Q, Yu H, et al. A prospective trial on initiation factor 4E (elF-4E ) overexpression and cancer recurrence in node positive breast cancer. Ann Surg,2005,242 (4) :584 -590.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部